Søren Galatius

Søren Galatius

Auto-generated profile, based on publicly available information

Søren Galatius

Department of Cardiology, Gentofte University Hospital, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2018 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
PBPhilip Brainin
Philip Brainin
SBSofie Reumert Biering-Sørensen
Sofie Reumert Biering-Sørensen
RMRasmus Møgelvang
Rasmus Møgelvang
MKMartina Chantal de Knegt
Martina Chantal de Knegt
FOFlemming Javier Olsen
Flemming Javier Olsen
TBTor Biering-Sørensen
Tor Biering-Sørensen

10 October 2014 in Diabetes Care
Verified
Journal Article
Open access
PDF file
SLSøren Lindberg
Søren Lindberg
JJJan S. Jensen
Jan S. Jensen
SPSune H. Pedersen
Sune H. Pedersen
SGSøren Galatius
Søren Galatius
JFJan Frystyk
Jan Frystyk
RMRasmus Mogelvang
Rasmus Mogelvang
OBJECTIVE Patients with acute myocardial infarction (MI) have increased risk of developing type 2 diabetes mellitus (T2DM). Adiponectin is an insulin-sensitizing hormone produced in adipose tissue, directly suppressing hepatic gluconeogenesis, stimulating fatty acid oxidation and glucose uptake in skeletal muscle and insulin secretion. In healthy humans, low plasma adiponectin levels associate with increased risk of T2DM; however, the relationship between adiponectin and T2DM in patients with MI has never been investigated. RESEARCH DESIGN AND METHODS We prospectively included 666 patients with ST-segment elevation MI, without diabetes, treated with percutaneous coronary intervention, from September 2006 to December 2008 at a tertiary cardiac center. Blood samples were drawn before intervention, and total plasma adiponectin was measured in all samples. During follow-up (median 5.7 years [interquartile range 5.3–6.1]) 6% (n = 38) developed T2DM. Risk of T2DM was analyzed using a competing risk analysis. RESULTS Low adiponectin levels were associated with increased risk of T2DM (P < 0.001). Even after adjustment for confounding risk factors (age, sex, hypertension, hypercholesterolemia, current smoking, previous MI, BMI, blood glucose, total cholesterol, HDL, LDL, triglyceride, estimated glomerular filtration rate, C-reactive protein, peak troponin I, and proatrial natriuretic peptide), low adiponectin levels remained an independent predictor of T2DM (hazard ratio [HR] 5.8 [2.3–15.0]; P < 0.001). Importantly, plasma adiponectin added to the predictive value of blood glucose, with the combination of high blood glucose and low plasma adiponectin, vastly increasing the risk of developing T2DM (HR 9.6 [3.7–25.3]; P < 0.001). CONCLUSIONS Low plasma adiponectin levels are independently associated with increased risk of T2DM in patients with MI and added significantly to the predictive value of blood glucose.

10 June 2015 in BMJ Open
Verified
Journal Article
Open access
PDF file
KHKim Wadt Hansen
Kim Wadt Hansen
RSR Soerensen
R Soerensen
MMM Madsen
M Madsen
JMJ K Madsen
J K Madsen
JJJ S Jensen
J S Jensen
SGS Galatius
S Galatius
Objectives To investigate for trends in sex-related differences in the invasive diagnostic–therapeutic cascade in a population of patients with acute coronary syndromes (ACS). Design A nationwide cohort study. Setting Administrative and clinical registries covering all hospitalisations, invasive cardiac procedures and deaths in the Danish population of 5.6 million inhabitants. Participants We included 52 565 patients aged 30–90 years who were hospitalised with a first ACS from January 2005 to November 2011. Follow-up was 60 days from the day of index admission. Main outcome measures Diagnostic coronary angiography, percutaneous coronary intervention or coronary artery bypass within 60 days of index admission. Results Women constituted 36%, were older, had more comorbidity and were less likely to be admitted to a hospital with cardiac catheterisation facilities than men. Mortality rates were similar for both sexes. Diagnostic coronary angiography was performed less frequently on women compared with men, both within 1 day (31% vs 42%; p<0.001) and within 60 days (67% vs 80%; p<0.001), yielding adjusted female–male HRs of 0.83 (0.79–0.87) and 0.86 (0.84–0.89), respectively.Among the 39 677 patients undergoing coronary angiography, non-obstructive coronary artery disease was more frequent among women than men (22% vs 9%; p<0.001). Women were less likely to undergo percutaneous coronary intervention (58% vs 72%; p<0.001) and coronary artery bypass (6% vs 11%, p0.05). Conclusions In this nationwide study, men were more likely to undergo an invasive approach than women when hospitalised with a first ACS—a difference persisting from 2005 to 2011. Future studies should focus on the potential mechanisms behind this differential treatment.

30 October 2019 in Diabetologia
Verified
Journal Article
Open access
PDF file
MJMagnus T. Jensen
Magnus T. Jensen
PSPeter Søgaard
Peter Søgaard
IGIda Gustafsson
Ida Gustafsson
JBJan Bech
Jan Bech
THThomas F. Hansen
Thomas F. Hansen
PRPeter Rossing
Peter Rossing
Cardiovascular disease is the most common comorbidity in type 1 diabetes. However, current guidelines do not include routine assessment of myocardial function. We investigated whether echocardiography provides incremental prognostic information in individuals with type 1 diabetes without known heart disease.


1 June 2011 in EuroIntervention
Verified
Journal Article
Closed access
AHAnders Hvelplund
Anders Hvelplund
RJRaban Jeger
Raban Jeger
RORemo Osterwalder
Remo Osterwalder
MBMajken Bredahl
Majken Bredahl
JMJan Kyst Madsen
Jan Kyst Madsen
SGSoren Galatius
Soren Galatius
The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)